Jump Financial, LLC Kempharm, Inc Transaction History

Jump Financial, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	N/A	-22,968 Reduced 69.18%	10,232 $50,000
Q4 2023 Oct 21, 2024	BUY	N/A	13,883 Added 71.87%	33,200 $164,000
Q4 2023 Feb 07, 2024	BUY	N/A	33,200 New	33,200 $164,000
Q1 2023 Oct 21, 2024	BUY	$4.13 - $6.27 $79,779 - $121,117	19,317 New	19,317 $106,000
Q1 2023 May 03, 2023	BUY	$4.13 - $6.27 $6,405 - $9,724	1,551 Added 8.73%	19,317 $106,000
Q4 2022 Feb 13, 2023	BUY	$4.12 - $5.62 $73,195 - $99,844	17,766 New	17,766 $81,000
Q2 2022 Aug 09, 2022	BUY	$4.02 - $5.21 $132,414 - $171,612	32,939 New	32,939 $147,000

117

26.1M

591K

242K

Ticker KMPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,493,600
Market Cap $170M
Description
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.